CIK 0001087294 · Non-accelerated filer<br>Smaller reporting company
CUMBERLAND PHARMACEUTICALS INC
Sign in to watch- Ticker
- CPIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- TN
- Entity type
- operating
- EIN
- 621765329
- Phone
- 615-255-0068
- Business address
- 1600 WEST END AVENUE, SUITE 1300, NASHVILLE,, TN, 37203
- 4 Grant or award Chairman and CEO acquired 35,000 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Grant or award Director acquired 500 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 3,000 shares (grant or award)
- 4 Grant or award Sr VP/Chief Commercial Officer acquired 3,000 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Option exercise Director acquired 7,600 shares (option exercise)
- 4 Grant or award Chief Financial Officer acquired 30,000 shares (grant or award)
- 4 Open-market sale Director sold 65,000 shares at $5.80 ($377,000)
- 4 Open-market sale Director sold 20,000 shares at $5.73 ($114,600)
- 4 Open-market sale Sr. VP & Corp. Secretary sold 2,618 shares at $5.73 ($15,001)
- 4 Open-market sale Director sold 3,786 shares at $5.73 ($21,694)
- 4 Open-market sale Director sold 1,310 shares at $5.73 ($7,506)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Sr. Vice President, Operations sold 1,700 shares at $5.91 ($10,047)
- 4 Returned to the company Vice President and CFO returned 3,000 shares (to the company)
- 4 Open-market sale Director sold 20,000 shares at $5.28 ($105,600)
- 4 Grant or award Sr. Vice President, Operations acquired 5,000 shares (grant or award)
Page 23 of 26 · 512 filings